Plantaglucid

General characteristics:

basic physical and chemical properties: granules from light brown with a grayish tint to dark brown with a grayish tint or dark gray in color, with a slight specific smell, sweet taste;
composition: 1 packet (2 g of granules) contains plantaglucide - 1 g;
excipients: refined sugar.

Release form.
Granules.

Pharmacotherapeutic group.
Means that affect the digestive system and metabolism. Means for the treatment of acid-dependent diseases. PBX code A02X.

Pharmacological properties.
Pharmacodynamics Plantaglucid - a plant-derived product, is a total preparation from the leaves of the large plantain (Plantago major L.). Contains a mixture of polysaccharides.
It has antispasmodic, anti-inflammatory and astringent effects. Reduces the tone of the smooth muscles of the stomach and intestines, reduces swelling of the folds of the gastric mucosa.
Pharmacokinetics Not investigated.

Indications for use.
Hypoacid gastritis (treatment and prevention of relapse), digestive disorders associated with decreased acidity of gastric juice.

Dosage and administration.
Assign inside, 20-30 minutes before meals, breeding in ¼ cup of warm water before taking.
Adults and children over 12 years of age are prescribed 1 packet 2-3 times a day. Children aged 6 to 12 are prescribed ½ packet 2-3 times a day, children under 6 years old - - packet 2-3 times a day. The duration of treatment during an exacerbation of gastritis is 3-4 weeks.
To prevent relapse, the drug is used in the same doses 1-2 times a day for 1-2 months.

Side effect.
The drug is usually well tolerated. Allergic reactions, heartburn are sometimes possible.

Contraindications
Hypersensitivity to the drug, hyperacid gastritis, peptic ulcer of the stomach and duodenum with high acidity.

Overdose.
In case of an overdose, side effects may intensify. Treatment: drug withdrawal, symptomatic therapy.

Features of the application.
Patients with diabetes should be aware that 1 packet of the drug contains 1 g of refined sugar.
Information on the use of the drug for the treatment of children under 6 years of age, in pregnant women and during lactation is not available.
The drug does not affect the ability to drive vehicles and the performance of potentially hazardous activities.

Interaction with other drugs.
There are no data on the interaction of the drug with other drugs.

Terms and conditions of storage. Store in a dry place at a temperature of 15С to 25С. Keep out of the reach of children. Shelf life is 5 years.

Vacation terms.
Over the counter.

Packaging.
2 g each in packages No. 1, No. 10, No. 30 or paired packages No. 2, No. 20 (No. 2x10), No. 25 (No. 2x12 and 1 package No. 1).